HDI Publications by date
Search will default to “all years” unless you filter by a specific year below.
Artificial Intelligence in Drug Design: Opportunities and Challenges
Thomas M, Boardman A, Garcia-Ortegon M, Yang H, de Graaf C, Bender AMethods in Molecular Biology (MIMB, volume ...
Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting
Knott CS, Heffernan K, Nikitas FS, Shukla U, Starkie-Camejo H. 812P Demographics and survival outcomes in patients ...
A registry study of relapsed or refractory multiple myeloma pre-exposed to 3 or more therapies including a proteasome inhibitor, an immunomodulatory agent and cd38-targeted monoclonal antibody therapy in England
Elsada A, Zalin-Miller A, Knott CS, Caravotas L. A registry study of relapsed or refractory multiple myeloma ...
Surgical decisions in older women with early breast cancer: patient and disease factors
Jauhari Y, Gannon MR, Dodwell D, Horgan K, Clements K, Medina J, et al.British Journal of Surgery, Volume 108, ...
Significant variation in treatment and survival outcomes in stage 2–4 ovarian cancer in England
Sundar SS, Knott CS, Paley L, et al. Significant variation in treatment and survival outcomes in stage 2–4 ovarian ...
Utilising Public Health England Datasets to Establish a Standing Cohort of Patients with Metastatic Bladder Cancer
Davies FJ. Knott CS, Kerr C, Adedokun L, Lockhat DM. Utilising Public Health England Datasets to Establish a ...
Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane project.
Shaaban AM, Hilton B, Clements K, Provenzano E, Cheung S, Wallis MG, et al.Br J Cancer 2021; ...
Geographic variation in ovarian, fallopian tube and primary peritoneal cancer treatment in England
Ovarian Cancer Audit Feasibility Pilot Steering Group. Geographic variation in ovarian, fallopian tube and primary ...
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome)
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and ...